Introducing GHK-Cu Copper Peptide Capsules: A Breakthrough in Oral Bioavailability

Discover the world's first orally bioavailable GHK-Cu Copper peptide capsules, enriched with Palmitoylethanolamide (PEA), stomach acid buffers, peptide absorption enhancers, SNAC, and Sodium Bicarbonate, all encapsulated in acid-resistant delayed-release, enteric-coated capsules.

Overcoming Oral Challenges

GHK-Cu in its raw form faces challenges in oral administration due to susceptibility to stomach acid and proteolytic enzymes. However, by shielding the peptide with SNAC, Sodium Bicarbonate, and employing delayed-release, enteric-coated capsules, a significant portion of the GHK-Cu peptide can traverse these barriers intact, reaching the gastrointestinal tract for systemic benefits.

Neuroprotective & Anti-Inflammatory Properties of PEA

Palmitoylethanolamide (PEA), a naturally occurring fatty acid, exhibits neuroprotective, anti-inflammatory, and analgesic properties. It interacts with various receptors, including CB1, CB2, PPARa, GRR55, TRPV1, and COX2, offering relief from acute and chronic pain while reducing inflammation.

Maximizing Absorption

Sodium Bicarbonate and Salcaprozate Sodium (SNAC), along with Delayed Release (DR) acid-resistant capsules, work synergistically to resist and buffer stomach acidity, enhancing GHK-Cu peptide absorption. The addition of SNAC + Bicarb buffers acidity, potentially improving absorption even if the acid-resistant capsules break or open.

Important Note

GHK-Cu (Copper Tripeptide) is an experimental biological peptide. The ingestion or use of this product is for experimental purposes only. LVLUP Health makes no health or therapeutic claims and assumes no responsibility or liability for health effects resulting from consuming this product; usage is at your own risk.